FINDRISC < 13 | Metabolic healthy | P1 | FINDRISC ≥ 13 | Metabolic syndrome | P2 | |
---|---|---|---|---|---|---|
Number of cases | 389 | 339 | 262 | 312 | ||
Age (years) | 40 ± 12 | 41 ± 13 | 0.89 | 47 ± 12 | 45 ± 12 | 0.83 |
Weight (kg) | 108.3 ± 22.0 | 104.7 ± 20.3 | 0.32 | 110.9 ± 19.9 | 114 ± 20.9 | 0.02 |
BMI (kg/m2) | 37.8 ± 6.2 | 37.5 ± 6.2 | 0.91 | 38.9 ± 5.8 | 39.0 ± 5.8 | 0.85 |
Waist (cm) | 113.9 ± 14.9 | 113.8 ± 15.6 | 0.98 | 119.4 ± 13.3 | 120.8 ± 13.2 | 0.88 |
Systolic BP (mmHg) | 126 ± 15 | 123 ± 13 | 0.76 | 132 ± 14 | 134 ± 14 | 0.82 |
Diastolic BP (mmHg) | 75 ± 11 | 73 ± 10 | 0.89 | 78 ± 11 | 80 ± 11 | 0.79 |
Triglycerides (mg/dl) | 125 (90–177) | 106 (80–130) | < 0.001 | 150 (108–198) | 179 (150–1229) | 0.01 |
Cholesterol (mg/dl) | 196 (175–226) | 197 (172–219) | 0.86 | 202 (173–229) | 201 (175–235) | 0.87 |
HDL cholesterol (mg/dl) | 48 (40–60) | 56 (48–66) | < 0.001 | 49 (40–60) | 42 (40–60) | 0.05 |
CT visceral fat (cm2) | 169 (115–225) | 155 (102–212) | < 0.001 | 206 (148–277) | 210 (158–267) | 0.20 |
CT subcutaneous fat (cm2) | 592 (592) | 601 (149) | 0.10 | 593 (138) | 584 (137) | 0.06 |
Total fat (cm2) | 773 ± 175 | 771 ± 183 | 0.68 | 812 ± 166 | 806 ± 159 | 0.52 |
Fasting glucose (mg/dl) | 84 (79–91) | 83 (78–91) | 0.84 | 90 (83–99) | 92 (82–101) | 0.83 |
2-h OGTT glucose (mg/dl) | 133 (114–154) | 131 (113–155) | 0.79 | 155 (129–186) | 152 (150–184) | 0.68 |
Hba1c (%) | 5.4 (5.2–5.6) | 5.5 (5.2–5.6) | 0.56 | 5.6 (5.4–5.9) | 5.6 (5.4–5.9) | 0.91 |
HbA1c (mmol/mol) | 36 (33–38) | 36 (33–38) | 0.97 | 38 (36–41) | 38 (36–40) | 0.98 |
Microalbuminuria (μg/min) | 8.0 (5–11) | 11 (5–12) | 0.43 | 10.0 (6–15) | 9.0 (6–15) | 0.66 |
FINDRISC score | 10 ± 2 | 11 ± 4 | 0.74 | 16 ± 3 | 13 ± 4 | 0.03 |
HOMA-S | 2.9 (1.9–4.8) | 2.7 (1.8–4.2) | 0.63 | 3.9 (2.5–6.0) | 4.2 (2.7–6.0) | 0.04 |
HOMA-B (%) | 252 (164–392) | 233 (152–369) | < 0.03 | 236 (147–337) | 261 (165–385) | < 0.01 |
Metbalic syndrome | 228/161 | 111/151 |